Potassium Chloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Potassium Chloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

POTASSIUM CHLORIDE DESCRIPTION




Inactive Ingredients

CLINICAL PHARMACOLOGY







INDICATIONS & USAGE

BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS, OR FOR PATIENTS WITH WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS.



POTASSIUM CHLORIDE CONTRAINDICATIONS

OVERDOSAGE).



WARNINGS

Hyperkalemia (see OVERDOSAGE)


Interaction with Potassium-Sparing Diuretics


Interaction with Angiotensin Converting Enzyme Inhibitors


Gastrointestinal Lesions



Metabolic Acidosis

PRECAUTIONS

General


Information for Patients







Laboratory Tests


Drug Interactions
WARNINGS).

Carcinogenesis, Mutagenesis, Impairment of Fertility


Pregnancy Category C


Nursing Mothers


Pediatric Use


Geriatric Use


POTASSIUM CHLORIDE ADVERSE REACTIONS

CONTRAINDICATIONS,WARNINGS, andOVERDOSAGE). There also have been reports of upper and lower gastrointestinal conditions including obstruction, bleeding, ulceration, and perforation (seeCONTRAINDICATIONSandWARNINGS).


OVERDOSAGE

CONTRAINDICATIONSandWARNINGS). It is important to recognize that hyperkalemia is usually asymptomatic and may be manifested only by an increased serum potassium concentration (6.5-8.0 mEq/L) and characteristic electrocardiographic changes (peaking of T-waves, loss P-waves, depression of S-T segments, and prolongation of the QT intervals). Late manifestations include muscle paralysis and cardiovascular collapse from cardiac arrest (9-12 mEq/L).







DOSAGE & ADMINISTRATION




WARNINGS).
NOTE:Potassium chloride extended-release tablets are to be swallowed whole without crushing, chewing or sucking the tablets.

HOW SUPPLIED

NDC68382and 1000 (NDC68382

STORAGE AND HANDLING


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Potassium Chloride


Potassium Chloride


Potassium Chloride

POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:52125-098(NDC:68382-600)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
potassium chloride 750 mg

Inactive Ingredients

Ingredient Name Strength
castor oil
COLLOIDAL SILICON DIOXIDE
D&C YELLOW NO. 10
MAGNESIUM STEARATE
PARAFFIN
titanium dioxide
VANILLIN
ALPHA-TOCOPHEROL
ETHYLCELLULOSES

Product Characteristics

Color Size Imprint Code Shape
yellow 15 mm a;KTAB OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:52125-098-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA018279 2012-09-21


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.